CN104106799B - 一种具有清除体内毒素作用的组合物及其制备方法 - Google Patents
一种具有清除体内毒素作用的组合物及其制备方法 Download PDFInfo
- Publication number
- CN104106799B CN104106799B CN201410394421.7A CN201410394421A CN104106799B CN 104106799 B CN104106799 B CN 104106799B CN 201410394421 A CN201410394421 A CN 201410394421A CN 104106799 B CN104106799 B CN 104106799B
- Authority
- CN
- China
- Prior art keywords
- mycelium
- composition
- effect
- purged body
- cypress
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000694 effects Effects 0.000 title claims abstract description 66
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 239000002158 endotoxin Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 32
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 32
- 235000008434 ginseng Nutrition 0.000 claims abstract description 32
- 241000218691 Cupressaceae Species 0.000 claims abstract description 26
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 23
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 23
- 241000123222 Hericium Species 0.000 claims abstract description 23
- 240000000599 Lentinula edodes Species 0.000 claims abstract description 23
- 241000837768 Gastrodia elata f. glauca Species 0.000 claims abstract description 20
- 241000208340 Araliaceae Species 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 18
- 238000009472 formulation Methods 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- 239000000428 dust Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 4
- 244000060234 Gmelina philippensis Species 0.000 claims description 3
- 241000577951 Hydnum Species 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 210000004072 lung Anatomy 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000002346 endotoxic effect Effects 0.000 abstract 1
- 230000000116 mitigating effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 235000001465 calcium Nutrition 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 235000014786 phosphorus Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000007443 Neurasthenia Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000000496 cardiotonic agent Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 201000000498 stomach carcinoma Diseases 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- LIEMBEWXEZJEEZ-INEUFUBQSA-N (2r,3r)-4-(6-aminopurin-9-yl)-2,3-dihydroxybutanoic acid Chemical compound NC1=NC=NC2=C1N=CN2C[C@@H](O)[C@@H](O)C(O)=O LIEMBEWXEZJEEZ-INEUFUBQSA-N 0.000 description 1
- RAFAVNTVTXJMAQ-UHFFFAOYSA-N (3-hydroxyfuran-2-yl)-phenylmethanone Chemical compound OC1=C(OC=C1)C(C1=CC=CC=C1)=O RAFAVNTVTXJMAQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- LIEMBEWXEZJEEZ-UHFFFAOYSA-N D-threo-Leutysin Natural products NC1=NC=NC2=C1N=CN2CC(O)C(O)C(O)=O LIEMBEWXEZJEEZ-UHFFFAOYSA-N 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 241000305491 Gastrodia elata Species 0.000 description 1
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 229930183217 Genin Natural products 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 241000175212 Herpesvirales Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000028872 Progressive muscular dystrophy Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000294142 Vascellum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000003167 anti-vitamin Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- -1 carrotene Chemical compound 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000000256 facial nerve Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 208000026591 functional gastric disease Diseases 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229930193974 gastrodin Natural products 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229940105631 nembutal Drugs 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 206010044652 trigeminal neuralgia Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种具有清除体内毒素作用的组合物及其制备方法,其特征在于:按重量百分比由黑木耳菌丝体40~56%、灵芝菌丝体8~17%、柏树菌丝体8~17%、香菇菌丝体5~13%、猴头菇菌丝体5~13%、乌天麻2~6%、林下参2~8%组成,本发明组合物的制备方法主要包括制备菌丝体、干燥、粉碎、混合等步骤,本发明的组合物具有清除体内毒素的作用,同时对雾霾中的微小颗粒引起的人体肺部病症及其他病症都具有治疗和缓解作用,所以具有抗雾霾清除体内垃圾的作用,市场需求非常广阔。
Description
技术领域
本发明涉及一种具有清除体内毒素作用的组合物,还涉及该组合物的制备方法。
背景技术
目前,世界范围内的环境恶化,中国是发展中国家,过去为了追求发展速度,使环境承受了巨大压力,在农业生产中大面积地使用化肥农药,过度地放牧,破坏了土壤、草地、森林等环境,在工业生产中由于粗放式管理,对资源的掠夺性开发,也对环境造成了严重的破坏,目前,大多数城市PM2.5超标,雾霾天气对城市居民的身体健康造成了严重影响。随着人类生活水平的不断提高,环境的污染,化学药品大量的应用,加上各种传染性疾病的传播,人们在日常饮食生活中,由于大量吸食农药、化肥、激素、高脂肪、高蛋白等一些对身体有害的食物,而我们体力劳动相对减少,使人的机体生理失去了平衡,一些垃圾毒素沉积于体内无法排出体外。目前,有一些食物具有清除体内垃圾毒素的作用,但效果差,见效慢,急需具有清除人体内毒素作用的保健食品,而且没有任何素副作用,对人体健康有益。
发明内容
本发明的目的是克服现有技术的不足,提供一种无毒副作用,并且能够提高人体免疫力,具有清除体内毒素作用的组合物。本发明的另一目的是提供一种该组合物的制备方法。
本发明的一种具有清除体内毒素作用的组合物,按重量百分比由黑木耳菌丝体40~56%、灵芝菌丝体8~17%、柏树菌丝体8~17%、香菇菌丝体5~13%、猴头菇菌丝体5~13%、乌天麻2~6%、林下参2~8%组成。
本发明的优选方案:按重量百分比由黑木耳菌丝体45~51%、灵芝菌丝体10~15%、柏树菌丝体10~15%、香菇菌丝体7~11%、猴头菇菌丝体7~11%、乌天麻3~5%、林下参4~6%组成。
本发明的最优选方案:按重量百分比由黑木耳菌丝体48%、灵芝菌丝体12%、柏树菌丝体13%、香菇菌丝体9%、猴头菇菌丝体9%、乌天麻4%、林下参5%组成。
以上所述的一种具有清除体内毒素作用的组合物,可制成任何一种药剂学上所述的剂型。
以上所述的一种具有清除体内毒素作用的组合物,优选的剂型是散剂、胶囊或片剂。
一种具有清除体内毒素作用的组合物的制备方法如下:
1、黑木耳菌丝体的制备方法:黑木耳菌种经过培养、发酵、烘干,得到黑木耳菌丝体;
2、灵芝菌丝体的制备方法:灵芝菌种经过培养、发酵、烘干,得到灵芝菌丝体;
3、柏树菌丝体的制备方法:野生柏树菌经过组织分离、培养、发酵、烘干,得到柏树菌丝体;
4、香菇菌丝体的制备方法:香菇菌种经过培养、发酵、烘干,得到香菇菌丝体;
5、猴头菇菌丝体的制备方法:野生猴头经过组织分离、培养、发酵、烘干,得到猴头菇菌丝体;
6、将上述制得的黑木耳菌丝体、灵芝菌丝体、柏树菌丝体、香菇菌丝体、猴头菇菌丝体分别进行粉碎、磨粉,将干燥后的乌天麻、林下参经过粉碎、磨粉,将上述菌丝体与乌天麻粉、林下参粉按比例混合均匀,就制得一种具有清除体内毒素作用的组合物的散剂;
7、把经灭菌处理好的散剂装入胶囊,就制得一种具有清除体内毒素作用的组合物的胶囊;
8、把经灭菌处理好的散剂进行压片处理,就制得一种具有清除体内毒素作用的组合物的片剂。
本发明一种具有清除体内毒素作用的组合物选择黑木耳菌丝体、灵芝菌丝体、柏树菌丝体、香菇菌丝体、猴头菇菌丝体、乌天麻、林下参进行组合,使得各种菌丝体和天麻、林下参的功效产生协同作用,从而提高机体免疫力,达到清除体内垃圾毒素的目的。各种组分主要成分及功效:
黑木耳菌丝体含有多糖、麦角淄醇、维生素B2、黑刺菌素、氨基酸、蛋白质、脂质、胡萝卜素、钾、钠、钙、镁、铜、锌、锰、磷等其他微量元素。
功效:
(1)养血驻颜,令人肌肤红润、容光焕发、瘦身美容。
(2)防止缺铁性贫血、降低血管内凝血、防止动脉硬化和冠心病、脑血栓。
(3)清除血管及胃肠垃圾、活血补血、健脾胃、助排泄、减轻胃肠负担,加速胃肠内毒素和废弃物的排泄。
(4)对胆、肾结石等内源性异物有明显化解功能。
(5)降胆固醇、血脂、防止动脉硬化。
(6)对无意中吃下的头发、谷物、谷壳、木渣、沙子、金属屑等异物有溶解与氧化作用。
(7)抗辐射及抗炎、抗溃疡、抗基因突变。
(8)强心、清肺润肺、调节内分泌、失调等功能。
灵芝菌丝体含有多糖、蛋白质、多种氨基酸、多肽类、麦角淄醇、甘露醇、生物碱、香豆精、淄体皂苷、腺嘌呤、多种酶、多种微量元素、维生素B2、维生素C等。主要功效:
(1)增强免疫功能、扶正固本、抗各种过敏体质、红斑狼疮、皮肤病、补内脏元气。
(2)白细胞减少症、白血病、长期感冒、咳喘、肺结核、淋巴结核。
(3)冠心病、心绞痛、心悸气短、心律失常、失眠多梦、降胆固醇、甘油三脂、预防动脉粥样硬化斑块的形成,改善微循环。
(4)对脾胃功能减弱、胃癌、肝癌、肿瘤都起到很好的作用。
(5)安神、镇静、抗惊厥、增智慧,对神经衰弱、头痛、头晕效果显著,对气血两虚、月经不调、痛经、闭经、更年期综合症提前更为适宜。
(6)糖尿病、进行性肌营养不良、萎缩性肌强直高源反应。抗衰老、排毒养颜。
(7)对癌症、肿瘤病人有辅助治疗,长期服用可养发护发。
柏树活性菌丝体富含真菌多糖、腺甘、嘌呤、嘧啶、高分子碳水化合物、纤维素等,对人体有保健治疗价值的有效成分。主要功效:
(1)增强机体免疫力,降血脂、降血压、抗癌。
(2)增强机体的稳定性、抑制肿瘤生长、抗衰老、抗过敏。
(3)抑制乙肝病毒复制,对急性肝炎、病毒性肝炎,药物对肝脏的损坏,酒精肝,肝脏疾病和肝癌都能起到保护和解毒的作用。
(4)可活化细胞、活化组织、改善微循环,双向调节人体适应机制。从而使机体恢复生理平衡。
(5)对肺结核有止痛、消炎、化积、化痰等功效。
(6)保肝、护肝、降肝火、解酒。
(7)促进儿童生长发育增长智力。
(8)抗肿瘤、防癌症。
(9)具有强肝清血功能,直接降低血液中所含的胆固醇,并疏通血管壁上的堆积物,同时也纯化了血液的品质。
香菇菌丝体含有一种分子量为100万的抗肿瘤成分——香菇多糖,含有降低血脂的成分——香菇太生,香菇腺嘌呤的衍生物,还含有抗病毒成分——干扰素的诱发剂:双链糖核酸,蛋白质18.64%、脂肪4.8%、碳水化合物71%、异亮氨酸、笨丙氨酸、蛋氨酸、苏氨酸、缬氨酸等7种人体必须的氨基酸,还含有大量的可转变维生素D的麦角淄醇和菌淄醇,B1、B2、PP及矿物盐和粗纤维,钙、磷、铁、尼克酸、可溶性无氨物质等。主要功效:
(1)降血脂、降血压、抗血栓、降血糖、安心安神、心悸、失眠、养精神、安魂魄、小儿惊厥、心腹胀满、补脑养骨髓。
(2)水湿停滞、小便不利、水肿、健脾补中益气不饥。对性病、梅毒、艾滋病、疱疹病毒、幽门螺旋杆菌、治风破血、膀胱湿热、大肠杆菌。
(3)抗病毒、防感冒、止咳、化痰、平喘、肺炎链球菌、孢子球菌有抑制作用,控制结核病的发生。
(4)健脾助消化:食欲不振、身体虚弱、大便不正常、便秘。开胃止呕、口苦舌干;逐水暖脾、生律益气、平火止泻,对肝脾肿大也有一定的好处。
(5)对婴幼儿因缺乏维生素D引起的血磷、血钙代谢障碍导致的佝偻病有很好的调节作用。
(6)对皮肤病、白血病、内分泌失调、快速增加免疫功能,使钙得到很好作用。
(7)有补肝肾、健脾胃、益气血、益智安神、养容颜之功效。
(8)对癌细胞有强烈的抑制作用:结肠癌、肺癌、乳腺癌。晚期癌症长期服用本品在化疗时间改善病人免疫功能,提高疗效、延长生存期。
猴头菇菌丝体含有人体必需的7种氨基酸,脂肪、维生素A、维生素B1、B2和尼克酸、多糖体、多肽及微量元素、钙、磷、食物纤维,还含有铜,铜是人体不可缺少的微量营养素。主要功效:
(1)对革兰氏阳性菌、幽门螺杆菌引起的胃肠道溃疡能修复受损粘膜有愈合作用,降低饮酒过量对胃肠道的伤害。
(2)对急慢性胃炎、萎缩性胃炎、浅表性胃炎、胃及十二指肠溃疡,胃寒、胃酸、胃胀、胃下垂、胃粘膜脱落,消化不良,厌食,偏食,胃功能失调有很好疗效。
(3)提高耐缺氧能力,降血脂,降胆固醇,防止动脉硬化引起的系列心脑血管疾病。
(4)长期服用可消除老年斑、皮肤细嫩美容。
(5)对胃癌、肠癌、喷门癌、消化道肿瘤有效率69.3%,消化道溃疡85.6%。
乌天麻含有大量天麻素,天麻苷元、香草醛、嘌呤类、海粗蛋白、脂肪、碳水化合物、纤维素、灰分等营养成分。主要功效:
(1)镇痛作用:对三叉神经痛、血管神经性头痛、脑血管性头痛、中毒性多发性神经炎等,有明显的镇痛效果。
(2)镇静作用:治疗神经衰弱和神经衰弱综合症病人,有效率分别为89.44%和86.87%,且能抑制咖啡因所致的中枢兴奋作用,还有加强戊巴妥钠的睡眠时间效应。
(3)抗惊厥作用:对面神经抽搐、肢体麻木、半身不遂、癫痫等有一定的疗效,还有缓解平滑肌痉挛,缓解心绞痛、胆绞痛的作用。
(4)降血压作用:治疗高血压,久服可平肝益气、利腰膝、强筋骨,还可增加外周及冠状动脉血流量,对心脏有保护作用。
(5)明目、增智作用:有明目和增强记忆力的作用,对学生楞保护大脑和视力,对人的大脑神经系统具有明显的保护和调节作用,能增强视神经的分辨能力,目前已用作高空飞行人员的脑保健药物,还可治疗老年性痴呆症。
林下参:人参自古以来拥有“百草之王”的美誉,更被东方医学界誉为“滋阴补生,扶正固本”之极品。林下参更是人参里的奇葩,模拟野生人参的生长环境,历经15年以上的生长周期,富含野生人参的珍贵营养成分,大补元气、回阳散逆、滋阴、益血、生津、强心,是世间不可多得的养生珍品!
1.人参对中枢神经系统具有兴奋作用,能减少疲劳感。
2.人参对心肌及血管有直接作用,一般在小剂量时兴奋,大剂量时抑制,亦有抗过敏性休克及强心的作用。
3.加强机体对有害因素的抵抗力,在大量失血或窒息而处于垂危状态时,服用人参,可使降至很低水平的血压稳固回升。促进损伤的愈合。有抗维生素B1、B2缺乏症的作用。
4.对因肾上腺素引起的高血糖动物有降低血糖的作用;对糖尿病患者除能自觉改善症状外,还有轻微的降血糖作用,并与胰岛素有协同作用。
5.能促进动物的性腺功能,小白鼠吃小量人参,能产生举尾现象。
6.对家兔也能增加体重,使血浆白蛋白的比值上升。
7.刺激造血器官,有改善贫血的作用。
纵观该具有清除体内毒素作用的组合物,是一个多种菌丝体组合在一起的配以天麻、林下参,以黑木耳菌丝体为主,其他菌丝体及天麻、林下参为辅,组成的复方,由于组方严谨、相得益彰、功效显著。黑木耳菌丝体具有清除血管及胃肠垃圾,加速胃肠内毒素和废弃物的排泄的作用。其他组分可以起到辅助作用,提高机体免疫力,调和阴阳、扶正祛邪,从而产生协同作用,达到清除体内毒素垃圾之功效。
具体实施方式
下面结合具体实施例对本发明进一步进行描述:
实施例1:
具有清除体内毒素作用的组合物,按重量百分比由黑木耳菌丝体40%、灵芝菌丝体17%、柏树菌丝体17%、香菇菌丝体13%、猴头菇菌丝体5%、乌天麻6%、林下参2%组成。
实施例2:
具有清除体内毒素作用的组合物,按重量百分比由黑木耳菌丝体56%、灵芝菌丝体8%、柏树菌丝体8%、香菇菌丝体9%、猴头菇菌丝体5%、乌天麻6%、林下参8%组成。
实施例3:
具有清除体内毒素作用的组合物,按重量百分比由黑木耳菌丝体45%、灵芝菌丝体15%、柏树菌丝体15%、香菇菌丝体11%、猴头菇菌丝体7%、乌天麻3%、林下参4%组成。
实施例4:
具有清除体内毒素作用的组合物,按重量百分比由黑木耳菌丝体51%、灵芝菌丝体10%、柏树菌丝体10%、香菇菌丝体7%、猴头菇菌丝体11%、乌天麻5%、林下参6%组成。
实施例5:
具有清除体内毒素作用的组合物,按重量百分比由黑木耳菌丝体48%、灵芝菌丝体12%、柏树菌丝体13%、香菇菌丝体9%、猴头菇菌丝体9%、乌天麻4%、林下参5%组成。
实施例6:
制备具有清除体内毒素作用的组合物:
制备黑木耳菌丝体:黑木耳菌种经过培养、发酵、烘干,得到黑木耳菌丝体;
制备灵芝菌丝体:灵芝菌种经过培养、发酵、烘干,得到灵芝菌丝体;
制备柏树菌丝体:野生柏树菌经过组织分离、培养、发酵、烘干,得到柏树菌丝体;
制备香菇菌丝体:香菇菌种经过培养、发酵、烘干,得到香菇菌丝体;
制备猴头菇菌丝体:野生猴头经过组织分离、培养、发酵、烘干,得到猴头菇菌丝体;
将上述制得的黑木耳菌丝体、灵芝菌丝体、柏树菌丝体、香菇菌丝体、猴头菇菌丝体分别进行粉碎、磨粉,将干燥后的乌天麻、林下参经过粉碎、磨粉,将上述菌丝体与乌天麻粉、林下参粉按比例混合均匀,就制得一种具有清除体内毒素作用的组合物的散剂;
把经灭菌处理好的散剂装入胶囊,就制得一种具有清除体内毒素作用的组合物的胶囊;
把经灭菌处理好的散剂进行压片处理,就制得一种具有清除体内毒素作用的组合物的片剂。
也可以把经灭菌处理好的散剂,装入袋子里,浸泡在酒中,制成具有清除体内毒素作用的组合物的保健酒。
Claims (6)
1.一种具有清除体内毒素作用的组合物,其特征在于:按重量百分比由黑木耳菌丝体40~56%、灵芝菌丝体8~17%、柏树菌丝体8~17%、香菇菌丝体5~13%、猴头菇菌丝体5~13%、乌天麻2~6%、林下参2~8%组成的剂型是任何一种药剂学上所述的剂型。
2.根据权利要求1所述的一种具有清除体内毒素作用的组合物,其特征在于:按重量百分比由黑木耳菌丝体45~51%、灵芝菌丝体10~15%、柏树菌丝体10~15%、香菇菌丝体7~11%、猴头菇菌丝体7~11%、乌天麻3~5%、林下参4~6%组成的剂型是任何一种药剂学上所述的剂型。
3.根据权利要求2所述的一种具有清除体内毒素作用的组合物,其特征在于:按重量百分比由黑木耳菌丝体48%、灵芝菌丝体12%、柏树菌丝体13%、香菇菌丝体9%、猴头菇菌丝体9%、乌天麻4%、林下参5%组成的剂型是任何一种药剂学上所述的剂型。
4.根据权利要求1~3任一所述的一种具有清除体内毒素作用的组合物,其特征在于:所述的剂型是任何一种药剂学上所述的剂型。
5.根据权利要求4所述的一种具有清除体内毒素作用的组合物,其特征在于:所述的剂型是散剂、胶囊或片剂。
6.根据权利要求1~5任一所述的一种具有清除体内毒素作用的组合物的制备方法,其特征在于,包含以下步骤:
1)黑木耳菌丝体的制备方法:黑木耳菌种经过培养、发酵、烘干,得到黑木耳菌丝体;
2)灵芝菌丝体的制备方法:灵芝菌种经过培养、发酵、烘干,得到灵芝菌丝体;
3)柏树菌丝体的制备方法:野生柏树菌经过组织分离、培养、发酵、烘干,得到柏树菌丝体;
4)香菇菌丝体的制备方法:香菇菌种经过培养、发酵、烘干,得到香菇菌丝体;
5)猴头菇菌丝体的制备方法:野生猴头经过组织分离、培养、发酵、烘干,得到猴头菇菌丝体;
6)将上述制得的黑木耳菌丝体、灵芝菌丝体、柏树菌丝体、香菇菌丝体、猴头菇菌丝体分别进行粉碎、磨粉,将干燥后的乌天麻、林下参经过粉碎、磨粉,将上述菌丝体与乌天麻粉、林下参粉按比例混合均匀,就制得一种具有清除体内毒素作用的组合物的散剂;或进一步的把经灭菌处理好的散剂装入胶囊,就制得一种具有清除体内毒素作用的组合物的胶囊;或者把经灭菌处理好的散剂进行压片处理,就制得一种具有清除体内毒素作用的组合物的片剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410394421.7A CN104106799B (zh) | 2014-08-13 | 2014-08-13 | 一种具有清除体内毒素作用的组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410394421.7A CN104106799B (zh) | 2014-08-13 | 2014-08-13 | 一种具有清除体内毒素作用的组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104106799A CN104106799A (zh) | 2014-10-22 |
CN104106799B true CN104106799B (zh) | 2016-08-24 |
Family
ID=51703944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410394421.7A Active CN104106799B (zh) | 2014-08-13 | 2014-08-13 | 一种具有清除体内毒素作用的组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104106799B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105769656B (zh) * | 2016-03-03 | 2018-03-30 | 厦门中妍生物科技有限公司 | 一种藏药材组合萃取物及其用途 |
CN107156801A (zh) * | 2016-03-08 | 2017-09-15 | 及长城 | 一种具有生发的活性菌丝群组合物及其制备方法 |
CN105994550A (zh) * | 2016-08-10 | 2016-10-12 | 翔天农业开发集团股份有限公司 | 一种猴头菇菌丝体饼干及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1148944A (zh) * | 1996-08-15 | 1997-05-07 | 尹作凤 | 一种保健粉剂 |
CN1283419A (zh) * | 2000-05-12 | 2001-02-14 | 钱师良 | 五芝保健饮料 |
CN101518336A (zh) * | 2009-04-14 | 2009-09-02 | 北京惠中铭捷生物科技有限公司 | 一种具有抗氧化功能的营养食品及其制备方法 |
CN101766273A (zh) * | 2008-12-31 | 2010-07-07 | 陈秀男 | 蘑菇多糖体组合物 |
CN103039955A (zh) * | 2012-12-28 | 2013-04-17 | 杨石 | 一种具有增强免疫力功能的保健食品 |
-
2014
- 2014-08-13 CN CN201410394421.7A patent/CN104106799B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1148944A (zh) * | 1996-08-15 | 1997-05-07 | 尹作凤 | 一种保健粉剂 |
CN1283419A (zh) * | 2000-05-12 | 2001-02-14 | 钱师良 | 五芝保健饮料 |
CN101766273A (zh) * | 2008-12-31 | 2010-07-07 | 陈秀男 | 蘑菇多糖体组合物 |
CN101518336A (zh) * | 2009-04-14 | 2009-09-02 | 北京惠中铭捷生物科技有限公司 | 一种具有抗氧化功能的营养食品及其制备方法 |
CN103039955A (zh) * | 2012-12-28 | 2013-04-17 | 杨石 | 一种具有增强免疫力功能的保健食品 |
Also Published As
Publication number | Publication date |
---|---|
CN104106799A (zh) | 2014-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hobbs | Medicinal mushrooms: an exploration of tradition, healing, and culture | |
KR101315656B1 (ko) | 엽록소가 함유된 미강의 발효추출물 및 그 제조방법 | |
CN103349284B (zh) | 一种桑椹酵素营养液及其制备方法 | |
CN104147383A (zh) | 一种抗肿瘤的组合物及其制备方法 | |
CN104126785A (zh) | 一种具有降糖作用的组合物及其制备方法 | |
CN107821721B (zh) | 一种具有治疗痛风的食疗组合物及其制备方法 | |
CN107212397A (zh) | 一种复合营养食用菌粉 | |
CN105595224A (zh) | 一种海参盐藻葡聚糖硒制剂及制备工艺 | |
CN102488278A (zh) | 一种具有双功能保健作用的复合真菌营养液 | |
CN101366521B (zh) | 天然型功能食品 | |
CN104982750A (zh) | 一种发酵型肉鸡配合饲料及其制备方法 | |
CN104106799B (zh) | 一种具有清除体内毒素作用的组合物及其制备方法 | |
CN106822190A (zh) | 一种增强免疫力的配方、组合物及其制备方法 | |
CN104431170A (zh) | 改善代谢综合征六高一脂的海洋生物活性多糖或寡糖颗粒茶饮 | |
Stengler | Health benefits of medicinal mushrooms | |
CN105288226A (zh) | 一种补肾壮阳的组合物及其制备方法 | |
CN102657304A (zh) | 一种具有促进消化和缓解体力疲劳双功能的保健食品 | |
CN102813199A (zh) | 一种预防及辅助治疗癌症、三高症及增强免疫力的保健食品 | |
CN1203168C (zh) | 一种制备食疗保健醋的方法及用该方法生产的食疗保健醋 | |
CN103908592A (zh) | 一种解毒的中药及其制备方法 | |
CN109043325A (zh) | 一种食用复合菌粉 | |
CN104906140A (zh) | 一种阿胶及其制备方法与相关设备 | |
CN107519400A (zh) | 一种具有降三高作用的生物组合物及其制备方法 | |
CN103933146A (zh) | 一种可调节人体免疫力的花粉制品 | |
CN106490268A (zh) | 一种用于解酒毒的茶饮及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190606 Address after: 133315 Great Wall Bacteria Industry in No. 1 Community of Hunchun Border Economic Cooperation Zone, Yanbian Korean Autonomous Prefecture, Jilin Province Patentee after: HUNCHUN GREAT WALL BACTERIA INDUSTRY TECHNOLOGY DEVELOPMENT CO., LTD. Address before: 133315 Great Wall Bacteria Industry in No. 1 Community of Hunchun Border Economic Cooperation Zone, Yanbian Korean Autonomous Prefecture, Jilin Province Patentee before: Ji Changcheng |